Discordant results from reverse sequence syphilis screening--five laboratories, United States, 2006-2010.
JD Radolf, G Bolan, IU Park, JM Chow… - MMWR: Morbidity & …, 2011 - search.ebscohost.com
JD Radolf, G Bolan, IU Park, JM Chow, JA Schillinger, P Pathela, S Blank, SN Zantao…
MMWR: Morbidity & Mortality Weekly Report, 2011•search.ebscohost.comThe article discusses the results of an analysis conducted by the US Centers for Disease
Control and Prevention (CDC) on reverse sequence screening for syphilis from 2006 to
2010. The analysis found that enzyme and chemiluminescence immunoassays (EIA/CIA)
had a nonreactive rapid plasma reagin (RPR) test. It also offered clinical information on
Treponema pallidum. An editorial comment on the report is also presented.
Control and Prevention (CDC) on reverse sequence screening for syphilis from 2006 to
2010. The analysis found that enzyme and chemiluminescence immunoassays (EIA/CIA)
had a nonreactive rapid plasma reagin (RPR) test. It also offered clinical information on
Treponema pallidum. An editorial comment on the report is also presented.
Abstract
The article discusses the results of an analysis conducted by the US Centers for Disease Control and Prevention (CDC) on reverse sequence screening for syphilis from 2006 to 2010. The analysis found that enzyme and chemiluminescence immunoassays (EIA/CIA) had a nonreactive rapid plasma reagin (RPR) test. It also offered clinical information on Treponema pallidum. An editorial comment on the report is also presented.
search.ebscohost.com